PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-339.14%
Both yoy net incomes decline, with AVGO at -1150.00%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-2.53%
Negative yoy D&A while AVGO is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-524.40%
Negative yoy deferred tax while AVGO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
155.21%
Well above AVGO's 168.75% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
86.81%
Some inventory rise while AVGO is negative at -350.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
403.71%
Growth well above AVGO's 211.76%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
10.77%
Some yoy increase while AVGO is negative at -50.00%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-146.15%
Negative yoy CFO while AVGO is 48.39%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
60.58%
Some CapEx rise while AVGO is negative at -75.00%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
65.75%
Purchases growth of 65.75% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-70.22%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-664.00%
We reduce yoy other investing while AVGO is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-12.36%
Both yoy lines negative, with AVGO at -75.00%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-74.51%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
100.00%
Similar buyback growth to AVGO's 100.00%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.